Register of
Medicinal Products
Human medicines
Veterinary medicines
Medical nutritions
User
Listings
Data download
Veterinary medicines
Search for medicinal products
Search for packages
ATC tree
Print
CINACALCET ACCORD
General data
Product class:
Authorized package
Medicinal product class:
For human use
Package code:
1667527
Name of medicinal product:
CINACALCET ACCORD
Active substances:
Cinacalcet
Estonian
,
English
,
Latin
ATC code:
H05BX01
Dosage form:
film-coated tablet
Route of administration:
oral use
Strengh:
30mg
Amount in package:
14TK
Legal status for supply*:
Subject to medicinal prescription
Class of active substance:
Additional information:
Indication:
Secondary hyperparathyroidism Adults Treatment of secondary hyperparathyroidism (HPT) in adult patients with end-stage renal disease (ESRD) on maintenance dialysis therapy. Paediatric population Treatment of secondary hyperparathyroidism (HPT) in children aged 3years and older with end?stage renal disease (ESRD) on maintenance dialysis therapy in whom secondary HPT is not adequately controlled with standard of care therapy (see section 4.4).
may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols, as appropriate (see section 5.1). Parathyroid carcinoma and primary hyperparathyroidism in adults Reduction of hypercalcaemia in adult patients with: • parathyroid carcinoma. • primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated.
Safety features:
Yes
Summary of product characteristics (SPC):
(last updated March 3, 2021)
Package information leaflet (PIL):
EST
(last updated May 21, 2020)
Labelling:
(last updated March 20, 2019)
Last imported to Estonia:
Never imported to Estonia
Marketing authorization
Marketing authorization holder:
Accord Healthcare B.V.
Marketing authorization number:
892315
Marketing authorization issued on:
November 11, 2015
Marketing authorization expires on:
Unlimited
Marketing authorization procedure type:
Decentralised
Prices
Reference price:
Under reference price:
Reference price of daily dose:
Entry/Changing date: March 3, 2021
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader from
here